InsightfulValue
← Home

Roche Holding
Roche Holding

Pharma / Pharma


📢 Press Releases

Date Press release
2025-05-30 01:00:00 Genentech’s Fenebrutinib Maintains Near-complete Suppression Of Disease Activity And Disability Progression For Up To Two Years In People With Relapsing Multiple Sclerosis
South san francisco, calif.--(business wire)--genentech, a member of the roche group (six: ro, rog; otcqx: rhhby), announced today new, 96-week data for fenebrutinib demonstrating that patients with relapsing multiple sclerosis (rms) maintained no disability progression and low levels of disease activity for up to two years. the latest results for this investigational bruton’s tyrosine kinase (btk) inhibitor from the phase ii fenopta open-label extension (ole) study were presented at the consor.
2025-05-23 09:00:00 Chmp Recommends Eu Approval Of Roche’s Itovebi For Pik3ca-mutated, Er-positive, Her2-negative, Advanced Breast Cancer
Basel, 23 may 2025 - roche (six: ro, rog; otcqx: rhhby) announced today that the european medicines agency’s committee for medicinal products for human use (chmp) has adopted a positive opinion for itovebi™ (inavolisib), in combination with palbociclib (ibrance®) and fulvestrant, for the treatment of adult patients with pik3ca-mutated, oestrogen receptor (er)-positive, human epidermal growth factor receptor 2 (her2)-negative, locally advanced or metastatic breast cancer, following recurrence on or within 12 months of completing adjuvant endocrine treatment. if approved, the itovebi-based regimen has the potential to transform the standard of care in this first-line setting, where treatments are currently limited.1 a final decision regarding the approval is expected from the european commission in the near future.
2025-05-23 01:10:00 Roche Announces New Collaboration With Broad Clinical Labs To Accelerate Adoption Of Cutting-edge Sbx Sequencing Technology
Basel, 23 may 2025 – roche (six: ro, rog; otcqx: rhhby) announced today a strategic collaboration with broad clinical labs to develop and pilot groundbreaking applications using roche’s recently unveiled next-generation sequencing (ngs) sequencing by expansion (sbx) technology. this collaboration will focus on harnessing the power of the sbx technology to transform clinical genomics and biomedical discovery. it will also aim to establish the sbx technology as a routine offering for fast, scalable sequencing for broad clinical lab’s research community.
2025-05-23 01:00:00 New Two-year Follow-up Of Genentech’s Columvi Extends Overall Survival In Relapsed Or Refractory Diffuse Large B-cell Lymphoma Patients
South san francisco, calif.--(business wire)--genentech, a member of the roche group (six: ro, rog; otcqx: rhhby), announced today two-year follow-up data from the phase iii starglo study. after a median follow-up of 24.7 months, data showed a 40% improvement in overall survival (os) for patients treated with columvi® (glofitamab-gxbm) in combination with gemcitabine and oxaliplatin (gemox) and median os was not reached, compared to 13.5 months for rituxan® (rituximab) plus gemox (r-gemox). the.
2025-05-22 11:45:00 Fda Approves Genentech’s Susvimo For Diabetic Retinopathy
South san francisco, calif.--(business wire)--genentech, a member of the roche group (six: ro, rog; otcqx: rhhby) announced today that the u.s. food and drug administration (fda) has approved susvimo® (ranibizumab injection) 100 mg/ml for the treatment of diabetic retinopathy (dr), a potentially blinding condition that affects almost 10 million people in the u.s. and more than 100 million people globally. it is the first and only fda-approved continuous delivery treatment shown to maintain visi.
2025-05-20 14:58:00 R2VuZW50ZW NoIFByb3Zp ZGVzIFVwZG F0ZSBPbiBG ZGEgQWR2aX NvcnkgQ29t bWl0dGVlIE 1lZXRpbmcg T24gQ29sdW 12aSBDb21i aW5hdGlvbi BGb3IgUGVv cGxlIFdpdG ggUmVsYXBz ZWQgT3IgUm VmcmFjdG9y eSBEaWZmdX NlIExhcmdl IEItY2VsbC BMeW1waG9t YQ==
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb2 c7IG90Y3F4 OiByaGhieS ksIGFubm91 bmNlZCB0b2 RheSB0aGF0 IGEgdS5zLi Bmb29kIGFu ZCBkcnVnIG FkbWluaXN0 cmF0aW9uIC hmZGEpIG9u Y29sb2dpYy BkcnVncyBh ZHZpc29yeS Bjb21taXR0 ZWUgKG9kYW MpIGRpc2N1 c3NlZCB0aG Ugc3VwcGxl bWVudGFsIG Jpb2xvZ2lj cyBsaWNlbn NlIGFwcGxp Y2F0aW9uIC hzYmxhKSBm b3IgY29sdW 12acKuIChn bG9maXRhbW FiLWd4Ym0p IGluIGNvbW JpbmF0aW9u IHdpdGggZ2 VtY2l0YWJp bmUgYW5kIG 94YWxpcGxh dGluIChnZW 1veCkgZm9y IHRoZSB0cm VhdG1lbnQg b2YgcGVvcG xlIHdpdGgg cmVsYXBzZW Qgb3IgcmVm cmFjdG9yeS Aoci9yKSBk aWZmdXNlIG xhcmdlIGIt Y2VsbCBseW 1waG9tYSAo ZGxiY2wpIH dobyBhcmUg bm90IGNhbm RpZGF0ZXMg Zm9yIGEu
2025-05-20 14:40:00 Um9jaGUgUH JvdmlkZXMg VXBkYXRlIE 9uIEZkYSBB ZHZpc29yeS BDb21taXR0 ZWUgTWVldG luZyBPbiBD b2x1bXZpIE NvbWJpbmF0 aW9uIEZvci BQZW9wbGUg V2l0aCBSZW xhcHNlZCBP ciBSZWZyYW N0b3J5IERp ZmZ1c2UgTG FyZ2UgQi1j ZWxsIEx5bX Bob21h
QmFzZWwsID IwIG1heSAy MDI1IC0gcm 9jaGUgKHNp eDogcm8sIH JvZzsgb3Rj cXg6IHJoaG J5KSBhbm5v dW5jZWQgdG 9kYXkgdGhh dCBhIHVzIG Zvb2QgYW5k IGRydWcgYW RtaW5pc3Ry YXRpb24gKG ZkYSkgb25j b2xvZ2ljIG RydWdzIGFk dmlzb3J5IG NvbW1pdHRl ZSAob2RhYy kgZGlzY3Vz c2VkIHRoZS BzdXBwbGVt ZW50YWwgYm lvbG9naWNz IGxpY2Vuc2 UgYXBwbGlj YXRpb24gKH NibGEpIGZv ciBjb2x1bX Zpwq4gKGds b2ZpdGFtYW IpIGluIGNv bWJpbmF0aW 9uIHdpdGgg Z2VtY2l0YW JpbmUgYW5k IG94YWxpcG xhdGluIChn ZW1veCkgZm 9yIHRoZSB0 cmVhdG1lbn Qgb2YgcGVv cGxlIHdpdG ggcmVsYXBz ZWQgb3Igcm VmcmFjdG9y eSAoci9yKS BkaWZmdXNl IGxhcmdlIG ItY2VsbCBs eW1waG9tYS AoZGxiY2wp IHdobyBhcm Ugbm90IGNh bmRpZGF0ZX MgZm9yIGF1 dG9sb2dvdX Mgc3RlbSBj ZWxsIHRyYW 5zcGxhbnQg KGFzY3QpLg ==
2025-05-14 16:00:00 Um9jaGUgUm VjZWl2ZXMg RmRhIEFwcH JvdmFsIEZv ciBUaGUgVm VudGFuYSBN ZXQgKHNwND QpIFJ4ZHgg QXNzYXkgQX MgVGhlIEZp cnN0IENvbX BhbmlvbiBE aWFnbm9zdG ljIFRvIElk ZW50aWZ5IE 5vbi1zcXVh bW91cyBOb2 4tc21hbGwg Q2VsbCBMdW 5nIENhbmNl ciBQYXRpZW 50cyBFbGln aWJsZSBGb3 IgVHJlYXRt ZW50IFdpdG ggRW1yZWxp cw==
QmFzZWwsID E0IG1heSAy MDI1IC0gcm 9jaGUgKHNp eDogcm8sIH JvZzsgb3Rj cXg6IHJoaG J5KSBhbm5v dW5jZWQgdG 9kYXkgdGhh dCB0aGUgZm RhIGhhcyBh cHByb3ZlZC B0aGUgdmVu dGFuYcKuIG 1ldCAoc3A0 NCkgcnhkeC Bhc3NheSwg dGhlIGZpcn N0IGNvbXBh bmlvbiBkaW Fnbm9zdGlj IGFwcHJvdm VkIHRvIGFp ZCBpbiBkZX Rlcm1pbmlu ZyBtZXQgKG Fsc28ga25v d24gYXMgYy 1tZXQpIHBy b3RlaW4gZX hwcmVzc2lv biBpbiBuc3 EtbnNjbGMg cGF0aWVudH MuIHRoZXNl IHBhdGllbn RzIG1heSBu b3cgYmUgZW xpZ2libGUg Zm9yIHRyZW F0bWVudCB3 aXRoIGFiYn ZpZeKAmXMg Yy1tZXQtdG FyZ2V0ZWQg dGhlcmFweS BlbXJlbGlz 4oSiICh0ZW xpc290dXp1 bWFiIHZlZG 90aW4tdGxs dikuMiwz
2025-05-13 01:00:00 VGVuLXllYX IgQXBoaW5p dHkgRGF0YS BTaG93IEdl bmVudGVjaO KAmXMgUGVy amV0YS1iYX NlZCBSZWdp bWVuIFJlZH VjZWQgVGhl IFJpc2sgT2 YgRGVhdGgg QnkgMTclIE luIEhlcjIt cG9zaXRpdm UgRWFybHkt c3RhZ2UgQn JlYXN0IENh bmNlcg==
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb2 c7IG90Y3F4 OiByaGhieS ksIHRoZSBi cmVhc3QgaW 50ZXJuYXRp b25hbCBncm 91cCAoYmln KSwgaW5zdG l0dXQganVs ZXMgYm9yZG V0IGNsaW5p Y2FsIHRyaW FscyBzdXBw b3J0IHVuaX QgYW5kIGZy b250aWVyIH NjaWVuY2Ug Zm91bmRhdG lvbiwgYW5u b3VuY2VkIH RvZGF5IHN0 YXRpc3RpY2 FsbHkgc2ln bmlmaWNhbn QgZmluYWwg b3ZlcmFsbC BzdXJ2aXZh bCAob3MpIH Jlc3VsdHMg ZnJvbSB0aG UgcGhhc2Ug aWlpIGFwaG luaXR5IHN0 dWR5IGluIH Blb3BsZSB3 aXRoIGh1bW FuIGVwaWRl cm1hbCBncm 93dGggZmFj dG9yIHJlY2 VwdG9yIDIg KGhlcjIpLX Bvc2l0aXZl IGVhcmx5LX N0YWdlIGJy ZWFzdCBjYW 5jZXIuIGFm dGVyIHRlbi B5ZWFycywg dGhlIHJpc2 sgb2YgZGVh dGggd2FzIH JlZHVjZWQg YnkgMS4=
2025-05-12 10:30:00 Um9jaGUgQW 5ub3VuY2Vz ICQ1NTAgTW lsbGlvbiBJ bnZlc3RtZW 50IFRvIEV4 cGFuZCBJdH MgSW5kaWFu YXBvbGlzIE RpYWdub3N0 aWNzIE1hbn VmYWN0dXJp bmcgSHVi
QW4gaW52ZX N0bWVudCBv ZiB1cCB0by AkNTUwIG1p bGxpb24gYn kgMjAzMCB3 aWxsIGVzdG FibGlzaCB0 aGUgaW5kaW FuYXBvbGlz IHNpdGUgYX MgYSBodWIg Zm9yIG1hbn VmYWN0dXJp bmcgb2Ygcm 9jaGXigJlz IGNvbnRpbn VvdXMgZ2x1 Y29zZSBtb2 5pdG9yaW5n IHNvbHV0aW 9uLiBleHBh bnNpb24gd2 lsbCBjcmVh dGUgaHVuZH JlZHMgb2Yg am9icyB3aG lsZSBhbHNv IGVuaGFuY2 luZyB1LnMu IHByb2R1Y3 Rpb24gY2Fw YWJpbGl0aW VzLg==
2025-05-12 08:30:00 Um9jaGUgQW 5kIEdlbmVu dGVjaCBBbm 5vdW5jZSBO ZXcgTm9ydG ggQ2Fyb2xp bmEgTWFudW ZhY3R1cmlu ZyBGYWNpbG l0eQ==
U291dGggc2 FuIGZyYW5j aXNjbywgY2 FsaWYuLS0o YnVzaW5lc3 Mgd2lyZSkt LWdlbmVudG VjaCwgYSBt ZW1iZXIgb2 YgdGhlIHJv Y2hlIGdyb3 VwIChzaXg6 IHJvLCByb2 c7IG90Y3F4 OiByaGhieS ksIGFubm91 bmNlZCB0b2 RheSBwbGFu cyB0byBpbn Zlc3QgbW9y ZSB0aGFuIC Q3MDAgbWls bGlvbiBpbi BhIG5ldyA3 MDAsMDAwIH NxdWFyZSBm b290IHN0YX RlLW9mLXRo ZS1hcnQgZH J1ZyBtYW51 ZmFjdHVyaW 5nIGZhY2ls aXR5IGluIG hvbGx5IHNw cmluZ3MsIG 5jLiB0aGUg cHJvamVjdC B3aWxsIGFk ZCBtb3JlIH RoYW4gNDAw IGhpZ2gtd2 FnZSBtYW51 ZmFjdHVyaW 5nIGpvYnMg d2hlbiB0aG Ugc2l0ZSBp cyBvcGVyYX Rpb25hbCBh bmQgbW9yZS B0aGFuIDEs NTAwIGNvbn N0cnVjdGlv biBqb2JzIG R1cmluZyBz aXRlIGRldm Vsb3BtZW50 LiB0aGUgbm V3IGZhY2ls aXR5IHdpbG wgdWx0aW1h dGVseSBzdX Bwb3J0IHJv Y2hlIGFuZC BnZW5lbnRl Y2jigJlzIG Z1dHVyZSBw b3J0Zm9sLg ==
2025-05-09 00:25:00 WmVhbGFuZC BQaGFybWEg QW5ub3VuY2 VzIENsb3Np bmcgT2YgQ2 9sbGFib3Jh dGlvbiBBbm QgTGljZW5z ZSBBZ3JlZW 1lbnQgV2l0 aCBSb2NoZQ ==
Q29tcGFueS Bhbm5vdW5j ZW1lbnQg4o CTIG5vLiAx MiAvIDIwMj UgemVhbGFu ZCBwaGFybW EgYW5ub3Vu Y2VzIGNsb3 Npbmcgb2Yg Y29sbGFib3 JhdGlvbiBh bmQgbGljZW 5zZSBhZ3Jl ZW1lbnQgd2 l0aCByb2No ZSBjb3Blbm hhZ2VuLCBk ZW5tYXJrLC BtYXkgOSwg MjAyNSDigJ MgemVhbGFu ZCBwaGFybW EgYS9zICji gJl0aGUgY2 9tcGFueeKA mSBvciDigJ x6ZWFsYW5k IHBoYXJtYe KAnSkgKG5h c2RhcTogem VhbCkgKGN2 ci1uby4=
2025-05-06 01:00:00 Um9jaGUgSW 50cm9kdWNl cyBJbm5vdm F0aXZlIEVs ZWNzeXMgUH JvLWMzIFRl c3QgVG8gSW 1wcm92ZSBQ cmVjaXNpb2 4gSW4gRXZh bHVhdGluZy BMaXZlciBG aWJyb3Npcy BTZXZlcml0 eQ==
QmFzZWwsID A2IG1heSAy MDI1IC0gcm 9jaGUgKHNp eDogcm8sIH JvZzsgb3Rj cXg6IHJoaG J5KSBhbm5v dW5jZWQgdG 9kYXkgdGhl IGxhdW5jaC BvZiBpdHMg ZWxlY3N5c8 KuIHByby1j MyB0ZXN0LC BhIG5ldyBk aWFnbm9zdG ljIHNvbHV0 aW9uIGRlc2 lnbmVkIHRv IGFzc2Vzcy B0aGUgc2V2 ZXJpdHkgb2 YgbGl2ZXIg Zmlicm9zaX MgaW4gcGF0 aWVudHMgc2 hvd2luZyBz aWducyBvZi BtZXRhYm9s aWMgZHlzZn VuY3Rpb27i gJNhc3NvY2 lhdGVkIHN0 ZWF0b3RpYy BsaXZlciBk aXNlYXNlIC htYXNsZCku IHRoZSB0ZX N0LCBkZXZl bG9wZWQgaW 4gcGFydG5l cnNoaXAgd2 l0aCBub3Jk aWMgYmlvc2 NpZW5jZSwg b2ZmZXJzIG NsaW5pY2lh bnMgYSBzaW 1wbGUgYW5k IGVmZmljaW VudCBtZXRo b2Qgb2YgaW RlbnRpZnlp bmcgcGF0aW VudHMgd2l0 aCBsaXZlci BmaWJyb3Np cyBvZiB2YX J5aW5nIHNl dmVyaXR5LC BlbmFibGlu ZyB0aW1lbH kgaW50ZXJ2 ZW50aW9uIG FuZCBhcHBy b3ByaWF0ZS BtYW5hZ2Vt ZW50IG9mIH RoZSBkaXNl YXNlLg==
2025-04-30 06:54:00 Qmxvb2QtYm FzZWQgQmlv bWFya2Vycy AoYmJiKSBN YXJrZXQgUm V2aWV3IDIw MjMtMjAyNC BBbmQgR3Jv d3RoIE9wcG 9ydHVuaXRp ZXMgMjAyNS 0yMDM1IEZl YXR1cmluZy BQcm9maWxl cyBPZiBLZX kgUGxheWVy cyAtIFJvY2 hlLCBTeXNt ZXggQ29ycG 9yYXRpb24s IE1pcnhlcy wgTWlub21p YywgQ3JlYX RpdmUgRGlh Z25vc3RpY3 MgQW5kIE1v cmU=
RHVibGluLC BhcHJpbCAz MCwgMjAyNS AoZ2xvYmUg bmV3c3dpcm UpIC0tIHRo ZSDigJlibG 9vZC1iYXNl ZCBiaW9tYX JrZXIgbWFy a2V0IC0gYS BnbG9iYWwg YW5kIHJlZ2 lvbmFsIGFu YWx5c2lzOi Bmb2N1cyBv biBkaXNlYX NlLCBhcHBs aWNhdGlvbi wgYW5kIGNv dW50cnktbG V2ZWwgYW5h bHlzaXMsID IwMjUtMjAz NeKAmSByZX BvcnQgaGFz IGJlZW4gYW RkZWQgdG8g cmVzZWFyY2 hhbmRtYXJr ZXRzLmNvbe KAmXMgb2Zm ZXJpbmcuIH RoZSBnbG9i YWwgYmxvb2 QtYmFzZWQg YmlvbWFya2 VyIG1hcmtl dCBpcyBwb2 lzZWQgZm9y IHN1YnN0YW 50aWFsIGdy b3d0aCwgZH JpdmVuIGJ5 IHRoZSBpbm NyZWFzaW5n IGRlbWFuZC Bmb3Igbm9u LWludmFzaX ZlIGRpYWdu b3N0aWMgdG VjaG5pcXVl cyBhbmQgYW R2YW5jZW1l bnRzIGluIG Jpb21hcmtl ciBkaXNjb3 ZlcnkgZm9y IGRpc2Vhc2 VzIHN1Y2gg YXMgY2FuY2 VyLCBuZXVy b2xvZ2ljYW wgZGlzb3Jk ZXJzLCBhbm QgdmFyaW91 cyBvdGhlcn Mu
2025-04-30 01:00:00 Q2htcCBSZW NvbW1lbmRz IEV1IExhYm VsIFVwZGF0 ZSBGb3IgUm 9jaGXigJlz IFBoZXNnby BUbyBBbGxv dyBBZG1pbm lzdHJhdGlv biBPdXRzaW RlIE9mIENs aW5pY2FsIF NldHRpbmdz
QmFzZWwsID MwIGFwcmls IDIwMjUgLS Byb2NoZSAo c2l4OiByby wgcm9nOyBv dGNxeDogcm hoYnkpIGFu bm91bmNlZC B0b2RheSB0 aGF0IHRoZS BldXJvcGVh biBtZWRpY2 luZXMgYWdl bmN54oCZcy Bjb21taXR0 ZWUgZm9yIG 1lZGljaW5h bCBwcm9kdW N0cyBmb3Ig aHVtYW4gdX NlIChjaG1w KSBoYXMgaX NzdWVkIGEg cG9zaXRpdm Ugb3Bpbmlv biByZWNvbW 1lbmRpbmcg YW4gdXBkYX RlIHRvIHRo ZSBldXJvcG VhbiB1bmlv biAoZXUpIG xhYmVsIGZv ciBwaGVzZ2 /CriwgYSBz dWJjdXRhbm VvdXMgKHNj KSBmaXhlZC 1kb3NlIGNv bWJpbmF0aW 9uIG9mIHBl cmpldGHCri AocGVydHV6 dW1hYikgYW 5kIGhlcmNl cHRpbsKuIC h0cmFzdHV6 dW1hYiksIG ZvciBodW1h biBlcGlkZX JtYWwgZ3Jv d3RoIGZhY3 RvciByZWNl cHRvciAyIC hoZXIyKS1w b3NpdGl2ZS BicmVhc3Qg Y2FuY2VyLi BpZiBhcHBy b3ZlZCwgYW RtaW5pc3Ry YXRpb24gb2 YgcGhlc2dv IG91dHNpZG Ugb2YgYSBj bGluaWNhbC BzZXR0aW5n IChzdWNoIG FzIGluIGEg cGVyc29u4o CZcyBob21l KSBieSBhIG hlYWx0aGNh cmUgcHJvZm Vzc2lvbmFs IHdpbGwgYm UgcG9zc2li bGUsIG9uY2 Ugc2FmZWx5 IGVzdGFibG lzaGVkIGlu IGEgY2xpbm ljYWwgc2V0 dGluZy4gYS BmaW5hbCBk ZWNpc2lvbi ByZWdhcmRp bmcgdGhlIG FwcHJvdmFs IGlzIGV4cG VjdGVkIGZy b20gdGhlIG V1cm9wZWFu IGNvbW1pc3 Npb24gaW4g dGhlIG5lYX IgZnV0dXJl Lg==
Roche Holding

📰 Browse additional press releases for Roche Holding!

Sign up for free or log in

✅ Download "The Checklist Value Investor — A Smarter Way to Pick Stocks" — totally free!

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal